Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasselon, T.
Right arrow Articles by Detmers, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasselon, T.
Right arrow Articles by Detmers, P. A.
(Journal of Leukocyte Biology. 2002;71:503-510.)
© 2002 by Society for Leukocyte Biology

Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38

Thierry Vasselon, William A Hanlon, Samuel D Wright and Patricia A. Detmers

Merck Research Laboratories, Rahway, New Jersey

Correspondence: Dr. Patricia A. Detmers, Merck Research Laboratories, 126 East Lincoln Avenue, RY80W-250, Rahway, NJ 07065. E-mail: patricia_detmers{at}merck.com

Early events in the response of cells to lipopolysaccharide (LPS) include activation of NF-{kappa}B and stress-activated MAP kinase p38. Recent studies have shown that the human Toll-like receptor 2 (TLR2) mediates activation of NF-{kappa}B in response to commercial preparations of LPS (comLPS), membrane lipoproteins, and Gram-positive bacterial products. Here, we show that expression of TLR2 in human embryonic kidney 293 cells enabled p38 phosphorylation in response to comLPS, a synthetic bacterial lipoprotein, and B. subtilis. Activation of p38 was confirmed by an in vitro kinase assay using ATF2 as substrate and by an assay measuring activation of the downstream effector of p38, MAP kinase-activated protein kinase in cells. Thus, TLR2 initiated the signaling pathway for p38 in response to bacterial products.

Key Words: lipopolysaccharide • signal transduction • cell-surface molecules • protein kinases • infectious immunity bacteria




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Nigou, T. Vasselon, A. Ray, P. Constant, M. Gilleron, G. S. Besra, I. Sutcliffe, G. Tiraby, and G. Puzo
Mannan Chain Length Controls Lipoglycans Signaling via and Binding to TLR2
J. Immunol., May 15, 2008; 180(10): 6696 - 6702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Vasselon, P. A. Detmers, D. Charron, and A. Haziot
TLR2 Recognizes a Bacterial Lipopeptide through Direct Binding
J. Immunol., December 15, 2004; 173(12): 7401 - 7405.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Aleman, P. Schierloh, S. S. de la Barrera, R. M. Musella, M. A. Saab, M. Baldini, E. Abbate, and M. C. Sasiain
Mycobacterium tuberculosis Triggers Apoptosis in Peripheral Neutrophils Involving Toll-Like Receptor 2 and p38 Mitogen Protein Kinase in Tuberculosis Patients
Infect. Immun., September 1, 2004; 72(9): 5150 - 5158.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Siedlar, M. Frankenberger, E. Benkhart, T. Espevik, M. Quirling, K. Brand, M. Zembala, and L. Ziegler-Heitbrock
Tolerance Induced by the Lipopeptide Pam3Cys Is Due to Ablation of IL-1R-Associated Kinase-1
J. Immunol., August 15, 2004; 173(4): 2736 - 2745.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Fernandez, P. Jose, M. G. Avdiushko, A. M. Kaplan, and D. A. Cohen
Inhibition of IL-10 Receptor Function in Alveolar Macrophages by Toll-Like Receptor Agonists
J. Immunol., February 15, 2004; 172(4): 2613 - 2620.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. J. Gehring, R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom
The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and Fc{gamma}R1 on Human Macrophages through Toll-Like Receptor 2
Infect. Immun., August 1, 2003; 71(8): 4487 - 4497.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Compton, E. A. Kurt-Jones, K. W. Boehme, J. Belko, E. Latz, D. T. Golenbock, and R. W. Finberg
Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2
J. Virol., April 15, 2003; 77(8): 4588 - 4596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Leukocyte Biology.